BG106209A - Лекарствени средства - Google Patents

Лекарствени средства

Info

Publication number
BG106209A
BG106209A BG06209A BG10620901A BG106209A BG 106209 A BG106209 A BG 106209A BG 06209 A BG06209 A BG 06209A BG 10620901 A BG10620901 A BG 10620901A BG 106209 A BG106209 A BG 106209A
Authority
BG
Bulgaria
Prior art keywords
therapeutic agents
human
compound
treatment
effective amount
Prior art date
Application number
BG06209A
Other languages
English (en)
Inventor
Alan BIRCH
David Heal
Original Assignee
Abbott Gmbh & Co. Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Gmbh & Co. Kg filed Critical Abbott Gmbh & Co. Kg
Publication of BG106209A publication Critical patent/BG106209A/bg

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Изобретението се отнася до метод за лечение на наднормено тегло и на свързаните с него болестни състояния при хора. По метода се прилага терапевтично ефективно количество от съединение с формула, включително неговите енантиомери и фармацевтично приемливи соли, в която формула R1 и R2 са независимо един от друг Н или метил, и липазен инхибитор, сизключение на орлистат, като съединението и липазният инхибитор се прилагат едновременно, поотделноили последователно.
BG06209A 1999-06-24 2001-12-11 Лекарствени средства BG106209A (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9914742.3A GB9914742D0 (en) 1999-06-24 1999-06-24 Therapeutic agents
PCT/EP2000/005544 WO2001000187A2 (en) 1999-06-24 2000-06-16 Pharmaceutical composition containing sibutramine and a lipase inhibitor

Publications (1)

Publication Number Publication Date
BG106209A true BG106209A (bg) 2002-09-30

Family

ID=10855953

Family Applications (1)

Application Number Title Priority Date Filing Date
BG06209A BG106209A (bg) 1999-06-24 2001-12-11 Лекарствени средства

Country Status (20)

Country Link
EP (1) EP1189638A2 (bg)
JP (1) JP2003503344A (bg)
KR (1) KR20020012293A (bg)
CN (1) CN1365287A (bg)
AU (1) AU5815100A (bg)
BG (1) BG106209A (bg)
BR (1) BR0011884A (bg)
CA (1) CA2376213A1 (bg)
CZ (1) CZ20014614A3 (bg)
GB (1) GB9914742D0 (bg)
HK (1) HK1050476A1 (bg)
HU (1) HUP0201880A3 (bg)
IL (1) IL147078A0 (bg)
MX (1) MXPA01013023A (bg)
NO (1) NO20016301D0 (bg)
PL (1) PL352387A1 (bg)
SK (1) SK18822001A3 (bg)
TR (1) TR200103704T2 (bg)
WO (1) WO2001000187A2 (bg)
ZA (1) ZA200110046B (bg)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6399826B1 (en) * 1999-08-11 2002-06-04 Sepracor Inc. Salts of sibutramine metabolites, methods of making sibutramine metabolites and intermediates useful in the same, and methods of treating pain
US7089666B2 (en) * 2003-06-06 2006-08-15 The Regents Of The University Of California Microfabricated vertical comb actuator using plastic deformation
US8604244B2 (en) 2010-07-02 2013-12-10 Reviva Pharmaceuticals, Inc. Compositions, synthesis, and methods of using cycloalkylmethylamine derivatives
CA2663254C (en) 2006-09-15 2016-04-19 Reviva Pharmaceuticals, Inc. Synthesis, methods of using, and compositions of cycloalkylmethylamines
CN101890017A (zh) * 2009-05-22 2010-11-24 北京奥萨医药研究中心有限公司 含有西布曲明和他汀类降脂药物的药物组合物及其用途
RU2642074C2 (ru) 2011-12-30 2018-01-24 Ревива Фармасьютикалс, Инк. Композиции, синтез и способы применения производных фенилциклоалкилметиламина

Also Published As

Publication number Publication date
ZA200110046B (en) 2003-03-06
IL147078A0 (en) 2002-08-14
JP2003503344A (ja) 2003-01-28
TR200103704T2 (tr) 2002-05-21
SK18822001A3 (sk) 2003-04-01
CN1365287A (zh) 2002-08-21
CA2376213A1 (en) 2001-01-04
NO20016301L (no) 2001-12-21
HUP0201880A3 (en) 2003-03-28
BR0011884A (pt) 2003-08-12
WO2001000187A2 (en) 2001-01-04
CZ20014614A3 (cs) 2004-02-18
HUP0201880A2 (hu) 2002-12-28
PL352387A1 (en) 2003-08-25
KR20020012293A (ko) 2002-02-15
WO2001000187A3 (en) 2001-11-15
NO20016301D0 (no) 2001-12-21
GB9914742D0 (en) 1999-08-25
MXPA01013023A (es) 2003-08-01
HK1050476A1 (zh) 2003-06-27
AU5815100A (en) 2001-01-31
EP1189638A2 (en) 2002-03-27

Similar Documents

Publication Publication Date Title
BG104476A (bg) Терапевтична форма на толтеродин с контролирано освобождаване
EG25822A (en) Quinolinyl-pyrrolopyrazoles
GB2254784B (en) Film-coated solid dosage form of anti-migraine drug
BG106586A (bg) Пиразолопиримидини като терапевтични средства
NZ514574A (en) Novel method of treatment
AU2002225772A1 (en) Therapeutic agents and methods of use thereof for treating an amyloidogenic disease
DE60316779D1 (de) Thiadiazolylpiperazinderivate geeignet für die behandlung bzw. prävention von schmerzen
GEP20043269B (en) Purine Derivatives, Method for Their Production and Composition Containing the Same
PL342099A1 (en) Therapeutic agents
MY119375A (en) Treatment of tinnitus using neuroprotective agents
CY1107465T1 (el) Μελαγατρανη για τη θepαπευτικη αντιμετωπιση φλεγμονων
BG106180A (bg) Фармацевтичен състав, съдържащ сибутрамин и орлистат
BG106209A (bg) Лекарствени средства
BG105997A (bg) Метод за контролиране увеличаването на теглото при прием на терапевтични средства
IL146962A0 (en) Aminotetralin derivatives for the therapy of cardiovascular diseases
EP1347754A4 (en) COMPOSITIONS FOR PREVENTION OF ADHESION
AU4918900A (en) Interferon-beta use in the treatment of ewing's family of tumors